Predicine

Predicine is a global molecular insights company committed to advancing precision medicine in oncology & infectious disease diagnostics. Predicine is developing proprietary technologies for cell-free DNA & cell-free RNA liquid biopsy to enable minimally invasive molecular diagnoses for early cancer detection, treatment selection, therapy response, minimal residual disease monitoring, & disease progression. The Predicine portfolio includes blood, urine, & tissue based NGS assays designed for globally harmonized use in clinical trial, companion diagnostic (CDx) development, & commercialization.